Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Yamshon

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Transplantation and Cellular Therapy|June 6, 2023
Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-AnalysisSamuel Yamshon, Caitlin Gribbin, Zhengming Chen, et al.
Blood Advances|March 26, 2026
Non-ICANS Neurologic Toxicity after BCMA CAR T: A systematic review and meta-analysis of 4630 multiple myeloma patientsHerman J van Besien, Gwynne Ozkan, Neela Easton, et al.
American Journal of Clinical Oncology|April 19, 2023
Long COVID in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 InfectionOlivia Fankuchen, Jennifer Lau, Mangala Rajan, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2024
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-AnalysisSamuel Yamshon, Caitlin Gribbin, Mohammad Alhomoud, et al.
Blood Advances|July 1, 2025
Comparative Infection Risk in CAR T vs Bispecific Antibodies in B cell Lymphoma: A Systematic Review and Meta-AnalysisHerman J van Besien, Neela Easwar, Michelle Demetres, et al.
Bone Marrow Transplantation|December 5, 2025
Age 60 or older is an independent predictor of outcomes after thiotepa-based autologous transplant in primary CNS lymphoma: a CIBMTR analysisNeela Easton, David G Goldfarb, Ahmed El-Naas, et al.
Bone Marrow Transplantation|August 21, 2023
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantationMohammad Alhomoud, Cynthia Magro, Surya Seshan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2020
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort StudyGagandeep Brar, Laura C Pinheiro, Michael Shusterman, et al.
Blood Advances|September 8, 2023
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphomaSamuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphomaMohammad Alhomoud, Michelle Foley, Mayumi Sugita, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|June 6, 2023
Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-AnalysisSamuel Yamshon, Caitlin Gribbin, Zhengming Chen, et al.
Blood Advances|March 26, 2026
Non-ICANS Neurologic Toxicity after BCMA CAR T: A systematic review and meta-analysis of 4630 multiple myeloma patientsHerman J van Besien, Gwynne Ozkan, Neela Easton, et al.
American Journal of Clinical Oncology|April 19, 2023
Long COVID in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 InfectionOlivia Fankuchen, Jennifer Lau, Mangala Rajan, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2024
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-AnalysisSamuel Yamshon, Caitlin Gribbin, Mohammad Alhomoud, et al.
Blood Advances|July 1, 2025
Comparative Infection Risk in CAR T vs Bispecific Antibodies in B cell Lymphoma: A Systematic Review and Meta-AnalysisHerman J van Besien, Neela Easwar, Michelle Demetres, et al.
Bone Marrow Transplantation|December 5, 2025
Age 60 or older is an independent predictor of outcomes after thiotepa-based autologous transplant in primary CNS lymphoma: a CIBMTR analysisNeela Easton, David G Goldfarb, Ahmed El-Naas, et al.
Bone Marrow Transplantation|August 21, 2023
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantationMohammad Alhomoud, Cynthia Magro, Surya Seshan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2020
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort StudyGagandeep Brar, Laura C Pinheiro, Michael Shusterman, et al.
Blood Advances|September 8, 2023
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphomaSamuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphomaMohammad Alhomoud, Michelle Foley, Mayumi Sugita, et al.
Pageof 4